Company intelligence / Profile preview

EndoCure

Haifa, Haifa District, Israelendocure.tech ↗

Ownership: Private
Development stage: Preclinical

Overview

EndoCure has developed Revealan™, an AI-powered robotic ultrasound imaging platform that integrates with standard ultrasound devices to provide high-resolution 3D volumetric data. This enables more sensitive and operator-independent detection, mapping, and staging of endometriosis lesions. The system aims to improve non-invasive diagnosis and management of endometriosis as well as surgical planning.

Therapeutic areas: Women's Health
Modalities: DeviceRobotic imaging platformAI-powered ultrasound imaging
Industry: Medical Imaging

Partnerships

Tech4eva Accelerator (investor/partner)

Beyond the preview

Go deeper on EndoCure.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on EndoCure.

Explore the full profile